Integration problems and turnaround strategies in a cross-border merger A clinical examination of the Pharmacia-Upjohn merger

Baily, 1972, Research and development costs and returns, Journal of Political Economy, 80, 70, 10.1086/259862 Barber, 1997, Detecting long-run abnormal stock returns, Journal of Financial Economics, 43, 341, 10.1016/S0304-405X(96)00890-2 Bradley, 1988, Synergistic gains from corporate acquisitions and their division between the stockholders of target and acquiring firms, Journal of Financial Economics, 21, 3, 10.1016/0304-405X(88)90030-X Comanor, 1986, The political economy of the pharmaceutical industry, Journal of Economic Literature, 24, 1178 Harris, 1991, The role of acquisitions in foreign direct investment, Journal of Finance, 46, 825, 10.2307/2328544 Reekie, 1978, Price and quality competition in the U.S. drug industry, Journal of Industrial Economics, 26, 223, 10.2307/2097866 Maquieira, 1998, Wealth creation versus redistributions in pure stock-for-stock mergers, Journal of Financial Economics, 48, 3, 10.1016/S0304-405X(98)00002-6 Zweifel, 1997